- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aldeyra Therapeutics Inc (ALDX)
Aldeyra Therapeutics Inc stock price live, this page displays NASDAQ ALDX stock exchange data. View the ALDX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aldeyra Therapeutics Inc real time stock price chart below.
What Is the Aldeyra Therapeutics Inc Stock Price Today?
The Aldeyra Therapeutics Inc stock price today is 1,170.
What Is the Stock Symbol for Aldeyra Therapeutics Inc?
The stock symbol for Aldeyra Therapeutics Inc is "ALDX."
What Stock Exchange Does Aldeyra Therapeutics Inc Trade On?
Aldeyra Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Aldeyra Therapeutics Inc a Good Stock to Buy?
Determining whether Aldeyra Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALDX quote. (ISIN: US01438T1060)
What Is the Aldeyra Therapeutics Inc Stock Price Today?
The Aldeyra Therapeutics Inc stock price today is 1,170.
What Is the Stock Symbol for Aldeyra Therapeutics Inc?
The stock symbol for Aldeyra Therapeutics Inc is "ALDX."
What Stock Exchange Does Aldeyra Therapeutics Inc Trade On?
Aldeyra Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Aldeyra Therapeutics Inc a Good Stock to Buy?
Determining whether Aldeyra Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALDX quote. (ISIN: US01438T1060)
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.150
1.310
52 wk Range
1.070
5.930
ALDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.1501.310
52 wk Range
1.0705.930
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALDX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
6.600
Upside
+464.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Form 4 Aldeyra The For: 11 June- Investing.com
Form 8K Aldeyra Therapeutics Inc For: 29 September- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.600
(+464.10% Upside)
Earnings
Latest Release
Jul 31, 2026
EPS / Forecast
-0,09 / -0,09
Revenue / Forecast
-- / 31,33M
Compare ALDX to Peers and Sector
Metrics to compare | ALDX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALDXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.1x | −1.5x | −0.4x | |
PEG Ratio | −0.06 | 0.00 | 0.00 | |
Price/Book | 1.9x | 2.6x | 2.6x | |
Price / LTM Sales | - | 52.4x | 3.0x | |
Upside (Analyst Target) | - | 269.8% | 58.2% | |
Fair Value Upside | Unlock | 5.1% | 7.7% | Unlock |
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal lymphoma and retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platforms, including ADX 248, ADX 246, and other novel RASP modulators for the treatment of various diseases associated with RASP. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Aldeyra (ALDX) Stock Price Today?
The Aldeyra stock price today is 1,170 USD.
What Stock Exchange Does Aldeyra Trade On?
Aldeyra is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Aldeyra?
The stock symbol for Aldeyra is "ALDX."
What Is the Aldeyra Market Cap?
As of today, Aldeyra market cap is 70,580M USD.
What Is Aldeyra's Earnings Per Share (TTM)?
The Aldeyra EPS (TTM) is -0,383.
When Is the Next Aldeyra Earnings Date?
Aldeyra will release its next earnings report on Nov 12, 2026.
From a Technical Analysis Perspective, Is ALDX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Aldeyra Stock Split?
Aldeyra has split 0 times.
How Many Employees Does Aldeyra Have?
Aldeyra has 6 employees.
What is the current trading status of Aldeyra (ALDX)?
As of Oct 04, 2026, Aldeyra (ALDX) is trading at a price of 1,170 USD, with a previous close of 1,170 USD. The stock has fluctuated within a day range of 1,150 USD to 1,310 USD, while its 52-week range spans from 1,070 USD to 5,930 USD.
What Is Aldeyra (ALDX) Price Target According to Analysts?
The average 12-month price target for Aldeyra is 6,600 USD, with a high estimate of 13 USD and a low estimate of 2 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +464,10% Upside potential.
What Is the ALDX Premarket Price?
ALDX's last pre-market stock price is 1,331 USD. The pre-market share volume is 1 010,000, and the stock has decreased by 0,041, or 3,180%.
What Is the ALDX After Hours Price?
ALDX's last after hours stock price is 1,200 USD, the stock has decreased by 0,030, or 2,560%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.